Advanced Prostate Cancer VL

Patient-Reported Outcomes (PROs): Optimizing Use in Clinical Practice- Alicia Morgans

Details
Alicia K. Morgans presents the rationale, benefits and barriers for Patient-Reported Outcomes (PROs): Optimizing Use in Clinical Practice from the Advanced Prostate Cancer Consensus Conference convened in March 2017. (presentation is 14 minutes) Select References: 1. Patient-Reported Outcomes — Harnessing Patients’ Voices to Improve Clinical Care Ethan Basch, M.D. N Engl J Med 2017; 376:105-108 Ja...

Systemic Treatment For Men With High Risk and Locally-Advanced Prostate Cancer Treated With Curative Intent- Nicholas James

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Epidemiology and Treatment Patterns of Advanced Prostate Cancer in Asian countries - Byung Ha Chung

Details
(Length of Presentation: 7 min) Byung Ha Chung, MD speaks to the epidemiology and treatments patterns of advanced prostate cancer specifically in Asia at the 2017 Advanced Prostate Cancer Consensus Conference (APCCC). He overviews the incidences and trends worldwide, reasons for rising incidences within Asia, mortality rates compared to the western world, mortality to incidence ratios according to...

Epidemiology and Management of Advanced Prostate Cancer in India- Vedang Murthy

Details
(Length of Presentation: 9 min) Vedang Murthy, MD presents the epidemiology and management of advanced prostate cancer specifically in India and begins by highlighting the difficulties in generalizing almost anything including prostate cancer in India due to the great diversity of the country. He overviews the incidence rate of prostate cancer along with the population demographics to articulate t...

Availability of Drugs: A Major Problem for Global Fight Against Cancer - Franco Cavalli

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

International Registry To Improve Outcomes in Men With Advanced Prostate Cancer-IRONMAN- Lorelei Mucci

Details
Lorelei Mucci presents at the 2017 Advanced Prostate Cancer Consensus Conference in St. Gallen, Switzerland, "International Registry To Improve Outcomes in Men With Advanced Prostate Cancer-IRONMAN". This exclusvie video lecture includes: background, study objectives, overview of design, and what make the IRONMAN registry so unique. Related Content: Watch: IRONMAN - A Better Understanding of the V...

Epidemiology and Treatment of Advanced Prostate Cancer in South America - Fernando Maluf

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Prostate Cancer in the Middle East- Raja B Khauli

Details
(Length of Presentation: 6 min) Raja Khauli, MD presents the incidence rates of advanced prostate cancer in the Middle East highlighting they are much higher than the rates that were presented at the conference for Japan or Asia. He explains it falls between Europe and Asia in terms of prostate cancer incidence rates with it being the highest in Lebanon. He addresses several causes for the rise of...

Lorelei Mucci and Philip Kantoff on Outcomes Research and the IRONMAN Project

Details
Lorelei Mucci and Phil Kantoff discuss the outcomes research of International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN) at the 2017 Advanced Prostate Cancer Consensus Conference (APCCC) in St. Gallen, Switzerland. Alicia Morgans interviews Lorelei Mucci and Phil Kantoff to discuss the changing treatment landscape for treating prostate cancer and the goal of the IR...

Ian Tannock on the Global view of Advanced Prostate Cancer

Details
Ian Tannock, presented, "Best use of "old and cheap" drugs", at the 2017 Advanced Prostate Cancer Consensus Conference in St. Gallen, Switzerland. Dr. Tannock and Charles Ryan, MD, discuss the greatest challenges faced globally in terms of prostate cancer and the lack of resources. Also, Dr. Tannock shares his views on what clinicians can do to improve the cost of drugs and the importance of educa...